Inclusion criteria |
1. Men suspected localized PCA based on at least one of the following criteria: |
(a) Repeated PSA value ≥ 4 ng/ml |
(b) Suspicious palpation of the prostate on digital rectal examination |
(c) Tumor-suspicious findings on transrectal ultrasound |
2. Age ≥ 45 and < 76 years |
3. No previous prostate biopsy |
4. Ability to give written informed consent, participate in and comply with study |
Exclusion criteria |
1. Allergy to the radiopharmaceutical 68 Ga-PSMA or to preparations with similar chemical structure |
2. Abuse of medications, drugs, or alcohol |
3. PSA level elevation > 100 ng/ml with resulting suspected advanced metastatic PCA |
4. Chronic ongoing severe renal disease defined by estimated creatinine clearance < 30 ml/min |